CIK 0000883975 · Non-accelerated filer<br>Smaller reporting company
Microbot Medical Inc.
Sign in to watch- Ticker
- MBOT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943078125
- Phone
- 908-938-5561
- Business address
- 25 RECREATION PARK DR SUITE 108, HINGHAM, MA, 02043
- Former names
- Microbot Medical Inc., STEMCELLS INC, CYTOTHERAPEUTICS INC/DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-06 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +38,095 | 38,095 | ||
| 2017-12-06 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +38,095 | 38,095 | ||
| 2017-12-06 | Bornstein Yoseph Director | Grant or award · Stock Option (Right to Buy) | +38,095 | 38,095 | ||
| 2017-12-06 | Bornstein Yoseph Director | Sale | −15,375 | $1.05 | $16K | 4,745,409 |
| 2017-12-05 | Bornstein Yoseph Director | Sale | −29,625 | $1.08 | $32K | 4,760,784 |
| 2017-12-05 | Waizer Yoav Zvi Director | Sale | −10,000 | $1.08 | $11K | 0 |
| 2017-12-04 | Waizer Yoav Zvi Director | Purchase | +10,000 | $1.10 | $11K | 10,000 |
| 2017-11-28 | Bornstein Yoseph Director | Sale | −45,000 | $1.07 | $48K | 4,790,409 |
| 2017-11-21 | Bornstein Yoseph Director | Sale | −45,000 | $1.21 | $54K | 4,835,409 |
| 2017-10-24 | Bornstein Yoseph Director | Sale | −25,000 | $1.14 | $28K | 4,880,399 |
| 2017-10-24 | Bornstein Yoseph Director | Sale | −25,000 | $1.13 | $28K | 4,880,399 |
| 2017-10-17 | Bornstein Yoseph Director | Sale | −25,000 | $1.17 | $29K | 4,930,399 |
| 2017-10-17 | Bornstein Yoseph Director | Sale | −25,000 | $1.16 | $29K | 4,930,399 |
| 2017-10-15 | Himelfarb Yehezkel COO and General Manager | Grant or award · Stock Option (Right to Buy) | +1,087,627 | 1,087,627 |
Page 6 of 6 · 114 trades